These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Oncogenes, differentiation markers and morphological criteria as prognostic parameters in non-small-cell bronchial carcinoma]. Thomas M; Junker K Dtsch Med Wochenschr; 1997 Oct; 122(43):1327-31. PubMed ID: 9410698 [No Abstract] [Full Text] [Related]
13. [Prognostic factors on surgical treatment for lung cancer]. Sekine Y; Fujisawa T Kyobu Geka; 2003 Jul; 56(8 Suppl):722-7. PubMed ID: 12910959 [TBL] [Abstract][Full Text] [Related]
14. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer. Nieder C; Andratschke N; Jeremic B; Molls M Anticancer Res; 2003; 23(6D):5117-23. PubMed ID: 14981976 [TBL] [Abstract][Full Text] [Related]
15. Predicaments in and prospects for lung cancer. Lillington GA Curr Opin Pulm Med; 1996 Jul; 2(4):261-2. PubMed ID: 9363149 [No Abstract] [Full Text] [Related]
16. [Bronchial carcinoma caused by genetic and environmental factors: genetic factors]. Nowak D Pneumologie; 1994 Aug; 48(8):526-8. PubMed ID: 7971891 [No Abstract] [Full Text] [Related]
17. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features. Grah J; Samija M; Juretić A; Sarcević B; Sobat H Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
19. Molecular genetic tumor markers in non-small cell lung cancer. Oyama T; Osaki T; Baba T; Nagata Y; Mizukami M; So T; Nakata S; Ichiki Y; Uramoto H; Sugaya M; Yoshimatsu T; Morita M; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K Anticancer Res; 2005; 25(2B):1193-6. PubMed ID: 15865065 [TBL] [Abstract][Full Text] [Related]
20. A novel molecular staging protocol for non-small cell lung cancer. Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]